Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$117.13 - $176.59 $1.79 Million - $2.7 Million
-15,279 Reduced 59.23%
10,515 $1.5 Million
Q1 2022

Apr 11, 2022

BUY
$126.46 - $235.05 $3.26 Million - $6.06 Million
25,794 New
25,794 $4.44 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aurora Investment Managers, Llc. Portfolio

Follow Aurora Investment Managers, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Investment Managers, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Aurora Investment Managers, Llc. with notifications on news.